• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VITAL ACCESS CORP VWING VASCULAR NEEDLE GUIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VITAL ACCESS CORP VWING VASCULAR NEEDLE GUIDE Back to Search Results
Model Number 00144
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Purulent Discharge (1812); Unspecified Infection (1930)
Event Date 08/24/2015
Event Type  Injury  
Manufacturer Narrative
Initially submitted to fda on 24 september 2015 as 2009273792-2015-00001, instead of 3009273792-2015-00001.Amended report with correct fei number (3009273792) submitted on 24 march 2016.
 
Event Description
(b)(6) received two vwing implants on (b)(6) 2015.On (b)(6) 2015, both vwing sites were cannulated.It was noted that the tech was not performing double skin prep.The tech was informed to perform double skin prep to prevent any possible infection but was noted a number of times continuing to use poor practice after the initial cannulation experience.On (b)(6), a vital access representative called the clinic and was informed that (b)(6) was having issues at their venous vwing site with pus coming from the site.(b)(6) was treated with abx for over a week, from (b)(6) and all cultures were negative per the clinic.The clinic informed the vital access representative that the pus might have resulted from (b)(6) not taking care of his access site or scratching the site but this claim was not confirmed.Cannulation was resumed on (b)(6).(b)(6) was actively followed on a weekly basis.On (b)(6), a vital access representative was informed by the clinic that the venous vwing had been removed secondary to a localized site infection and that the site culture was positive for s.Aureus.No bloodstream infection present.(b)(6) arterial vwing remains implanted and in use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VWING VASCULAR NEEDLE GUIDE
Type of Device
VWING
Manufacturer (Section D)
VITAL ACCESS CORP
448 e winchester st
suite 250
salt lake city UT 84107
Manufacturer (Section G)
VITAL ACCESS CORP.
448 e. winchester st.
suite 250
salt lake city UT 84107
Manufacturer Contact
mark crawford
448 e. winchester st.
suite 250
salt lake city, UT 84107
8014339390
MDR Report Key5522411
MDR Text Key41034354
Report Number3009273792-2015-00001
Device Sequence Number1
Product Code PFH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130873
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial
Report Date 09/24/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/24/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model Number00144
Device Lot Number14-0126
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Device Age3 MO
Date Manufacturer Received08/26/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AV FISTULA NEEDLES
Patient Outcome(s) Required Intervention;
Patient Age44 YR
-
-